Key proteins and genetic materials
We develop and produce key proteins and genetic materials for biopharma and food industry. Industry collaboration is an important pillar of our strategy.
Promising Q3 2022
With the outlicensing of our HSV-2 vaccine program to Eurocine Vaccines (Sweden) Redbiotec has achieved one of its biggest goals [...]
Successful expression of kappa casein
Redbiotec has successfully expressed the kappa casein, an essential protein for the production of animal-free milk, in an innovative expression [...]
Expansion of platform – adding bifidobacteria and yeast
Redbiotec has expanded its platform by adding further microorganisms. In order to express proteins and small molecules at high yield, [...]
BIO Digital 2020
Date: June 8-12, 2020 At a time when collaboration is more vital than ever, the Redbiotec team looks forward [...]